β-D-Glucan is a biomarker for the fungal infection, candidiasis. In a clinical study β-D-glucan levels was found to have possible usefulness in prediction of patient outcomes.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
